+ Watch PETS
on My Watchlist
A nationwide pet pharmacy, that markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses direct to the consumer.
My little Sh*t-Zu Oscar recomended this stock to me.(Wag O' the tail)I'm telling you Oscar has mad stock picking skillz.Still strikes me as funny that I can't mention Oscar without the profanity filter kicking in... ; )Cheers!
Who wouldn’t want to take advantage of a stock trading at an Enterprise Value to EBITDA of 4.7x, with a 5% annual dividend yield, $50 million in cash (only a market cap of $200 million), and no debt. When you see something like this typically something is wrong with the underlying business model and unfortunately this is the case for PETS. The cracks are beginning to show, stock price is falling and earnings are weakening. The Company is a retailer with no true competitive advantage. Like many of these stocks, Amazon is going to eat their lunch. Amazon already offers the majority of their products at much lower prices. Given PETS margins, scalability, and overall size, this could be a short fight. I am staying away from this one.
Oscars DOG enough to admit when he's wrong, and has moved on to sniffing other trees.No benefit from ending the Caps pick though. And honestly the metrics you put up really were'nt that bad. So he's willing to bury this pick in the backyard for awile and see what happens.Full Disclosure- no real kibble was risked on this Caps pick.
Oscar strikes again!Man, that dog was freakin' smart. Been two years now and I find myself researching puppies... uh-oh!
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions